These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10876313)

  • 1. [Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries].
    Tanyi J; Páy A; Rigó J; Nagy B; Papp Z
    Orv Hetil; 2000 May; 141(21):1115-9. PubMed ID: 10876313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
    Palacios J; Gamallo C
    Cancer Res; 1998 Apr; 58(7):1344-7. PubMed ID: 9537226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.
    Fujioka T; Takebayashi Y; Kihana T; Kusanagi Y; Hamada K; Ochi H; Uchida T; Fukumoto M; Ito M
    Oncol Rep; 2001; 8(2):249-55. PubMed ID: 11182035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin mutation in carcinoma of the uterine endometrium.
    Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S
    Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
    Furlong MT; Morin PJ
    Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
    Garcia-Rostan G; Tallini G; Herrero A; D'Aquila TG; Carcangiu ML; Rimm DL
    Cancer Res; 1999 Apr; 59(8):1811-5. PubMed ID: 10213482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation.
    Saegusa M; Okayasu I
    J Pathol; 2001 May; 194(1):59-67. PubMed ID: 11329142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
    Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
    Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
    Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma.
    Schlosshauer PW; Pirog EC; Levine RL; Ellenson LH
    Mod Pathol; 2000 Oct; 13(10):1066-71. PubMed ID: 11048799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
    Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
    Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.